Results 21 to 30 of about 292,990 (265)

Arg-GlcNAcylation on TRADD by NleB and SseK1 Is Crucial for Bacterial Pathogenesis

open access: yesFrontiers in Cell and Developmental Biology, 2020
Death receptor signaling is critical for cell death, inflammation, and immune homeostasis. Hijacking death receptors and their corresponding adaptors through type III secretion system (T3SS) effectors has been evolved to be a bacterial evasion strategy ...
Juan Xue   +16 more
doaj   +1 more source

Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells

open access: yesFrontiers in Cell and Developmental Biology, 2022
Binding of TRAIL to its death domain-containing receptors TRAIL-R1 and TRAIL-R2 can induce cell death and/or pro-inflammatory signaling. The importance of TRAIL and TRAIL-R1/R2 in tumor immune surveillance and cancer biology has meanwhile been well ...
Anna-Christina Rambow   +10 more
doaj   +1 more source

Identification of a ligand for the death-domain-containing receptor Apo3 [PDF]

open access: yesCurrent Biology, 1998
The tumor necrosis factor (TNF) cytokine family regulates development and function of the immune system [1]. TNF is expressed primarily by activated lymphocytes and macrophages and induces gene transcription or apoptosis in target cells [2,3]. We have identified a novel relative of TNF that binds to the recently discovered, death-domain-containing ...
Marsters, Scot A.   +5 more
openaire   +2 more sources

Inhibition of Wnt/β-catenin signaling by a soluble collagen-derived frizzled domain interacting with Wnt3a and the receptors frizzled 1 and 8. [PDF]

open access: yesPLoS ONE, 2012
The Wnt/β-catenin pathway controls cell proliferation, death and differentiation. Several families of extracellular proteins can antagonize Wnt/β-catenin signaling, including the decoy receptors known as secreted frizzled related proteins (SFRPs), which ...
Ismaïl Hendaoui   +8 more
doaj   +1 more source

PD-L1 is expressed on human activated naive effector CD4+ T cells. Regulation by dendritic cells and regulatory CD4+ T cells.

open access: yesPLoS ONE, 2021
The T cell expression of various co-signalling receptors from the CD28 immunoglobulin superfamily (Inducible T cell co-stimulator (ICOS), Programmed cell death 1(PD-1), cytotoxic T lymphocyte associated protein 4 (CTLA-4), B and T lymphocyte attenuator ...
Fabienne Mazerolles   +1 more
doaj   +2 more sources

Structure of TRAF Family: Current Understanding of Receptor Recognition

open access: yesFrontiers in Immunology, 2018
Tumor necrosis factor receptor–associated factor (TRAF) proteins are key signaling molecules that function in various cellular signaling events including immune response, cell death and survival, development, and thrombosis.
Hyun H. Park
doaj   +1 more source

Functional roles in cell signaling of adaptor protein TRADD from a structural perspective

open access: yesComputational and Structural Biotechnology Journal, 2020
TRADD participates in various receptor signaling pathways and plays vital roles in many biological activities, including cell survival and apoptosis, in different cellular contexts.
Zhen Li, Wensu Yuan, Zhi Lin
doaj   +1 more source

The transmembrane domains of TNF-related apoptosis-inducing ligand (TRAIL) receptors 1 and 2 co-regulate apoptotic signaling capacity. [PDF]

open access: yesPLoS ONE, 2012
TNF-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor (TNF) ligand family that exerts its apoptotic activity in human cells by binding to two transmembrane receptors, TRAILR1 and TRAILR2.
Simon Neumann   +5 more
doaj   +1 more source

N-terminal and C-terminal domains of calmodulin mediate FADD and TRADD interaction.

open access: yesPLoS ONE, 2015
FADD (Fas-associated death domain) and TRADD (Tumor Necrosis Factor Receptor 1-associated death domain) proteins are important regulators of cell fate in mammalian cells. They are both involved in death receptors mediated signaling pathways and have been
Giuliana Papoff   +7 more
doaj   +1 more source

The Features of Checkpoint Receptor—Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition

open access: yesBiomedicines, 2022
To date, certain problems have been identified in cancer immunotherapy using the inhibition of immune checkpoints (ICs). Despite the excellent effect of cancer therapy in some cases when blocking the PD-L1 (programmed death-ligand 1) ligand and the ...
Anna Kuzevanova   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy